Fifty two percent of US employers report difficulty filling positions. The average time to fill stands at 36 days. Biotech compensation benchmarks include median wages of 95310 dollars for biological scientists and 101000 dollars for medical scientists.
Key Takeaways
- 43% of workers in manufacturing occupations in OECD countries report that they need additional training to keep up with changes in the workplace (relevant to biotech plant roles where process and equipment evolve)
- 3.4% year-over-year growth in employment for professional, scientific, and technical services in the U.S. in 2023 (a proxy category including biotech R&D and related services)
- 824,000 people were employed in U.S. medical and diagnostic laboratory services in 2023, indicating a sizable labor pool for biotech testing and lab operations
- In 2023, U.S. workers in the pharmaceutical and medicine manufacturing sector had an average hourly wage of $32.18, informing biotech compensation baselines
- In 2023, the U.S. average total compensation for production supervisors and operating for lab/processing teams was above $100k annually (used in HR budgeting for biotech shift leaders)
- In 2023, the U.S. median annual wage for medical and clinical laboratory technologists was $58,530 (laboratory technician compensation benchmark)
- The U.S. median annual wage for biological scientists was $95,310 in 2023, setting another benchmark for biotech hiring
- The U.S. median annual wage for medical scientists (except epidemiologists) was $101,000 in 2023, a direct compensation reference for biotech HR offers
- The U.S. median annual wage for biochemists and biophysicists was $99,940 in 2023, indicating pay benchmarks for biotech recruiting
- In the U.S. healthcare and social assistance sector, the quits rate was 2.3% in 2023 (quits benchmark relevant to biotech-adjacent employers competing for talent)
- In 2022, 56% of employees said pay is a major reason they stay, directly tying compensation to biotech retention
- Workplace injuries requiring days away from work in the U.S. averaged 202,000 per year in 2022 for healthcare and social assistance (safety outcomes tied to retention in lab environments)
- In 2022, Mercer reported that 70% of organizations use talent analytics to improve hiring or development (affects biotech workforce planning)
- In 2022, 63% of organizations used performance management software (helps biotech track lab/clinical KPIs)
- In 2024, 54% of HR teams reported using generative AI for content creation for HR workflows (affects biotech HR communications and training materials)
Biotech hiring stays tight as skill and compliance training needs rise, while wages, benefits, and AI-driven recruiting shape retention.
Related reading
01 · Category
Workforce Supply6 stats
01
43% of workers in manufacturing occupations in OECD countries report that they need additional training to keep up with changes in the workplace (relevant to biotech plant roles where process and equipment evolve)
02
3.4% year-over-year growth in employment for professional, scientific, and technical services in the U.S. in 2023 (a proxy category including biotech R&D and related services)
03
824,000 people were employed in U.S. medical and diagnostic laboratory services in 2023, indicating a sizable labor pool for biotech testing and lab operations
04
52% of employers in the U.S. report difficulty filling positions (labor availability pressure affecting specialized life-science roles)
05
The U.S. unemployment rate averaged 3.6% in 2023, a macro labor-market context affecting biotech hiring tightness
06
The average time-to-fill for open positions in the U.S. was 36 days in 2022 (general hiring process metric relevant to biotech talent acquisition)
Interpretation
Workforce Supply Interpretation
From a workforce supply perspective, hiring in life sciences appears increasingly constrained as 52% of US employers report difficulty filling positions and the average time-to-fill reached 36 days in 2022, suggesting that even with a strong labor pool like 824,000 workers in medical and diagnostic laboratory services in 2023, biotech still needs faster talent matching and ongoing training to keep up with change.
02 · Category
Compensation And Benefits9 stats
01
In 2023, U.S. workers in the pharmaceutical and medicine manufacturing sector had an average hourly wage of $32.18, informing biotech compensation baselines
02
In 2023, the U.S. average total compensation for production supervisors and operating for lab/processing teams was above $100k annually (used in HR budgeting for biotech shift leaders)
03
In 2023, the U.S. median annual wage for medical and clinical laboratory technologists was $58,530(laboratory technician compensation benchmark)
04
The U.S. median annual wage for clinical research coordinators (SOC 29-2031, as an approximate) was $60,570in 2023 (HR offer benchmark for clinical biotech operations)
05
In 2023, the U.S. median annual wage for pharmacists was $128,570(biotech clinical operations often compete for these roles indirectly)
06
In 2023, U.S. employers offered paid leave benefits to 91% of employees (benefits packages used to compete for lab and R&D talent)
07
In 2023, U.S. average private-sector health insurance premiums were $8,435for single coverage and $23,968 for family coverage (benefits cost influencing HR budgets)
08
KFF reports that deductibles for covered workers increased to an average of $1,655in 2023 (employee cost-sharing affects benefits competitiveness)
09
In 2023, the U.S. ECI (Employment Cost Index) for wages and salaries rose 4.1% year-over-year, affecting biotech payroll cost growth assumptions
Interpretation
Compensation And Benefits Interpretation
For the Compensation and Benefits angle, 2023 data shows pay is climbing across biotech-adjacent roles, with median wages like $58,530 for medical and clinical laboratory technologists and $60,570 for clinical research coordinators, while paid leave is offered to 91% of employees, underscoring that employers are using both higher compensation and widely available benefits to attract and retain specialized talent.
03 · Category
Talent Acquisition6 stats
01
The U.S. median annual wage for biological scientists was $95,310in 2023, setting another benchmark for biotech hiring
02
The U.S. median annual wage for medical scientists (except epidemiologists) was $101,000in 2023, a direct compensation reference for biotech HR offers
03
The U.S. median annual wage for biochemists and biophysicists was $99,940in 2023, indicating pay benchmarks for biotech recruiting
04
76% of biopharma companies reported using external recruiters at least sometimes for scientific/clinical roles in 2024 (talent sourcing intensity)
05
The U.S. median annual wage for clinical laboratory technologists and technicians was $57,800in 2023 (lab workforce offers for biotech testing operations)
06
LinkedIn data cited that 76% of hiring managers want to use AI to streamline recruiting by 2024, impacting biotech HR workflow
Interpretation
Talent Acquisition Interpretation
For talent acquisition in biotech, pay remains a strong pull point with 2023 median wages topping $95,310 for biological scientists and $101,000 for medical scientists, while recruiting is becoming more AI and externally sourced as 76% of biopharma companies use external recruiters at least sometimes and LinkedIn data shows 76% of hiring managers want to use AI to streamline recruiting by 2024.
More related reading
04 · Category
Retention And Turnover6 stats
01
In the U.S. healthcare and social assistance sector, the quits rate was 2.3% in 2023 (quits benchmark relevant to biotech-adjacent employers competing for talent)
02
In 2022, 56% of employees said pay is a major reason they stay, directly tying compensation to biotech retention
03
Workplace injuries requiring days away from work in the U.S. averaged 202,000 per year in 2022 for healthcare and social assistance (safety outcomes tied to retention in lab environments)
04
In 2023, 68% of employees reported receiving recognition at least once a week (recognition correlates with retention in knowledge work)
05
In 2022, 27% of employees left their job due to insufficient growth opportunities, signaling upskilling and career paths as biotech retention levers
06
In 2022, the U.S. labor force participation rate was 62.5%, affecting the pool available for retention-to-avoid rehiring cycles
Interpretation
Retention And Turnover Interpretation
For retention and turnover in biotech-adjacent workforces, employees cite pay as a key factor for staying at 56% and career growth as a dealbreaker with 27% leaving for insufficient opportunities, suggesting compensation and clear advancement paths are the biggest levers to reduce quits beyond the relatively low 2.3% 2023 benchmark quit rate in the U.S. healthcare and social assistance sector.
05 · Category
Hr Technology And Analytics3 stats
01
In 2022, Mercer reported that 70% of organizations use talent analytics to improve hiring or development (affects biotech workforce planning)
02
In 2022, 63% of organizations used performance management software (helps biotech track lab/clinical KPIs)
03
In 2024, 54% of HR teams reported using generative AI for content creation for HR workflows (affects biotech HR communications and training materials)
Interpretation
Hr Technology And Analytics Interpretation
HR technology and analytics is rapidly expanding in biotech as shown by Mercer’s 70% adoption of talent analytics for hiring or development in 2022 and Gartner’s 63% use of performance management software in 2022, with LinkedIn reporting that by 2024 54% of HR teams are already using generative AI to create content for HR workflows.
06 · Category
Training And Compliance6 stats
01
In 2022, the U.S. fatal work injury rate was 3.5 per 100,000 workers (safety compliance pressure affecting biotech manufacturing and lab settings)
02
In 2023, FDA received 6,796 human drug safety reports (MedWatch) per month on average, increasing compliance expectations for safety-trained personnel
03
In 2021, adherence to GxP training is essential: FDA-regulated firms often require documented training for GLP/GCP/GMP activities (training documentation is a compliance standard)
04
In the U.S., 75% of organizations reported using formal training for compliance, according to the Training Industry Report 2023 (relevant to HR compliance programs for biotech quality)
05
In 2023, ICH’s Q9 (Quality Risk Management) remains a core guideline affecting biotech quality training; Q9 states a risk management approach should be applied to identify, evaluate, and control risks to quality
06
In 2022, the OECD reported that 6% of workers in high-risk sectors experienced workplace accidents leading to at least 4 days absence, underscoring training impact in biotech facilities
Interpretation
Training And Compliance Interpretation
Training and compliance in biotech are tightening fast because safety expectations are rising alongside oversight, with the US fatal work injury rate at 3.5 per 100,000 in 2022 and FDA averaging 6,796 human drug safety reports per month in 2023 while most organizations already use formal compliance training at 75%.
report visual · Comparison
Biotech HR tight labor market vs. retention levers
Employers report difficulty filling roles while benefits, recognition, and growth opportunities act as retention drivers in biotech-adjacent labor markets.
In 2023, 68% of employees reported receiving recognition at least once a week (recognition correlates with retention in 68%
52% of employers in the U.S. report difficulty filling positions (labor availability pressure affecting specialized life
52%
In 2022, 27% of employees left their job due to insufficient growth opportunities, signaling upskilling and career paths
27%
In the U.S. healthcare and social assistance sector, the quits rate was 2.3% in 2023 (quits benchmark relevant to biotec
2.3%
source-verifiedbls.gov · gallup.com · linkedin.com2023
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
Gabrielle Fontaine. (2026, February 13). HR In The Biotech Industry Statistics. Gitnux. https://gitnux.org/hr-in-the-biotech-industry-statistics
MLA
Gabrielle Fontaine. "HR In The Biotech Industry Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/hr-in-the-biotech-industry-statistics.
Chicago
Gabrielle Fontaine. 2026. "HR In The Biotech Industry Statistics." Gitnux. https://gitnux.org/hr-in-the-biotech-industry-statistics.
Sources & references
36 datasets cited across this report · attribution is report-level
+21 additional datasets cited (not shown individually)